Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Marinus Pharmaceuticals Inc. buy BiotechBee

Start price
€1.22
08.09.24 / 30%
Target price
€4.00
31.05.27
Performance (%)
22.95%
End price
-
29.09.24
Summary
This prediction is currently being closed. The BUY prediction by BiotechBee currently has a performance of 22.95%. BiotechBee has a follow-up prediction for Marinus Pharmaceuticals Inc. where he still thinks Marinus Pharmaceuticals Inc. is a Buy. BiotechBee has 30% into this prediction
Performance without dividends (%)
Name 1w
Marinus Pharmaceuticals Inc. -
iShares Core DAX® 3.523%
iShares Nasdaq 100 1.026%
iShares Nikkei 225® -0.063%
iShares S&P 500 0.557%

According to BiotechBee what are the pros and cons of Marinus Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Marinus Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 22.95%
Target price 4.000
Change
Ends at 31.05.27

Buy mit Kursziel 4,0

In the thread Trading Marinus Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 22.95%
Target price 4.000
Change
Ends at 31.05.27

Buy beendet

Current prediction by BiotechBee for Marinus Pharmaceuticals Inc.

buy
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.61
29.09.24
€3.00
30.06.27
-
27.09.24

Could be very worthwhile Investment >20% year